Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official, Peter Marks, had been forced to resign, the most high-
By Manas Mishra -Sanofi said on Thursday it would buy back 5 billion euros ($5.21 billion) in shares this year and could be more active with acquisitions in the near term as the drugmaker moves
Eli Lilly said on Tuesday its recently approved obesity treatment Zepbound is now available in U.S. pharmacies and could cost $550 a month for
U.S.-based Eli Lilly and Denmark's Novo Nordisk have struck gold with their weight-loss drugs, sending their shares to stratospheric levels and putting them
Amgen shares headed for their best session since 2009 on Friday after the U.S. drugmaker hinted at encouraging interim trial data on its experimental
Stock influencer Keith Gill, known as "Roaring Kitty," unveiled a 6.6% stake in Chewy on Monday, a surprise move that alarmed executives
Healthcare companies who profit from treating obese and overweight patients are trying to convince investors that powerful new weight-loss drugs won't
Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday,
The European Union's drugs regulator has rejected Eisai and Biogen's Leqembi treatment for early Alzheimer's disease, saying the risk of serious brain
The U.S. government will provide free COVID-19 tests by mail starting in late September, as it kicks off a fall campaign urging eligible Americans to
The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the most vulnerable people in
Walgreens Boots Alliance said on Tuesday it would shut 1,200 stores over the next three years as new CEO Tim Wentworth plots a turnaround at the struggling
Spirit AeroSystems, a key supplier to U.S. planemaker Boeing, warned on Tuesday there was "substantial doubt" the company would be able to continue as a
Health insurance companies are reassessing the risks for their top executives after the murder of UnitedHealthcare CEO Brian Thompson on Wednesday
Pfizer on Tuesday said it does not expect the Trump administration to make major changes to vaccine policy next year even as the president-elect has put
Trump has begun another trade war. Here's a timeline of how we got here
Canada's leader laments lost friendship with US in town that sheltered stranded Americans after 9/11
Chinese EV giant BYD's fourth-quarter profit leaps 73%
You're an American in another land? Prepare to talk about the why and how of Trump 2.0
Chalk talk: Star power, top teams and No. 5 seeds headline the women's March Madness Sweet 16
Purdue returns to Sweet 16 with 76-62 win over McNeese in March Madness
